![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication March 3, 2008.
Revised May 28, 2008.
Accepted for publication May 29, 2008.
Many phase I and II enzymes are under hormonal regulation, resulting in sex-related expression patterns. This sex-related enzyme expression can result in differential metabolism of physiologically active endogenous substances, altered xenobiotic clearance, as well as differences in susceptibility to drug toxicities. Treatment of female Sprague-Dawley (SD) rats with 5 mg testosterone propionate/kg/d, 2 mL/kg SC for 8 days resulted in induction of renal uridine diphosphoglucuronosyltransferase 1A1 (UGT1A1), as determined by immunoblot and probe substrate activity. Glucuronidation activity for mycophenolic acid, a substrate for rat UGT1A1, 1A6 and 1A7, was significantly elevated approximately two-fold in renal microsomes from testosterone propionate treated animals. Protein expression of rat UGT1A1 was also dramatically increased, while 1A6 and 1A7 remained unchanged as a result of treatment. Male SD rats were determined to express greater renal UGT1A1 than age-matched female rats. These data support the androgen regulation of rat renal UGT 1A1.
Key words:
gender differences, glucuronidation, phase II drug metabolism, renal elimination, UDP glucuronyltransferases